Newsbenzinga
Forte Biosciences Skin Pigmentation Disorder Drug Shows Strong Efficacy, Safety In Early Study
· Published
Article summary
Forte Biosciences reported positive Phase 1b vitiligo data, with FB102 showing significant facial repigmentation and favorable safety.
An excerpt from the original article.
Comments —
Loading comments…